Vitamin E should not be used to treat Alzheimer’s dementia or mild cognitive impairment: updated Cochrane evidence

vitamin E pillsThere is evidence that free radicals may contribute to the processes of cognitive impairment and so there has been considerable interest in recent years in whether vitamin E with its potential to protect against the damaging effects of free radicals might be useful in the treatment of mild cognitive impairment (MCI) and Alzheimer’s dementia (AD). The Cochrane Dementia and Cognitive Improvement Group has updated its review exploring this approach, which now includes two randomized trials involving people with AD and one with people with MCI, comparing vitamin E with placebo.

What did they find?

  • No or little benefit from using vitamin E to treat AD or MCI

How good is the evidence?

  • Data from the studies could not be combined as the two AD studies had different outcome measures: performance-based tasks in one and reaching certain end points (such as institutionalisation or loss of activities of daily living) in the other. The MCI study needed to be evaluated separately as it involved people with one particular type of MCI
  • The methods used were not always fully reported
  • One study had high drop-out rates and did not give reasons for this

What next?

The reviewers make some important points. They highlight that other research has shown that vitamin E, especially in the large doses used in treatment studies, may be associated with potentially serious side effects. Taken alongside the lack of evidence for its effectiveness, they recommend that vitamin E should not be used for the treatment of Alzheimer’s dementia and mild cognitive impairment. They also recommend that future trials should not be restricted to the alpha-tocopherol form of vitamin E and should consider assessing oxidant-antioxidant balance to determine whether the vitamin E treatment is having the desired effects.

Links:

Farina N, Isaac MGEKN, Clark AR, Rusted J, Tabet N. Vitamin E for Alzheimer’s dementia and mild cognitive impairment. Cochrane Database of Systematic Reviews 2012, Issue 11. Art. No.: CD002854. DOI: 10.1002/14651858.CD002854.pub3. http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD002854.pub3/abstract;
jsessionid=CA66645A45F39C290EC25FC0E82B4D6C.d04t02

Cochrane summary
http://summaries.cochrane.org/CD002854/vitamin-e-should-not-be-used-for-the-treatment-of-mild-cognitive-impairment-mci-and-alzheimers-dementia-ad

Mental Elf:
http://www.thementalelf.net/publication-types/systematic-review/new-cochrane-review-says-that-vitamin-e-should-not-be-used-to-treat-dementia/

Advertisements

One thought on “Vitamin E should not be used to treat Alzheimer’s dementia or mild cognitive impairment: updated Cochrane evidence

  1. It might be just me….

    But it seems to me like Vitamin E (and D, B,…and the rest of them in many, though not all, instances, and throw in trace elements into the pot as well for good measure) are apparent ‘solutions’ that have been looking for a ‘problem’ to solve for ages. Should this be considered a social problem rather than a medical problem? If it were we would not need the RCTs (and other studies) looking at these, along with the resources that go into conducting them. There are very legitimate reasons to do a systematic review, but does this provide a medical answer that will not change attitudes and beliefs for those who were never looking for a medical answer?

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s